Your browser doesn't support javascript.
loading
Hyperhomocysteinemia Promotes Cardiac Hypertrophy in Hypertension.
Deng, Yawen; Li, Zhitong; An, Xiangbo; Fan, Rui; Wang, Yao; Li, Jiatian; Yang, Xiaolei; Liao, Jiawei; Xia, Yunlong.
Afiliación
  • Deng Y; Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Li Z; Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • An X; Department of Interventional Therapy, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Fan R; Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Wang Y; Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Li J; Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Yang X; Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Liao J; Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Xia Y; Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Oxid Med Cell Longev ; 2022: 1486157, 2022.
Article en En | MEDLINE | ID: mdl-36046692
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hiperhomocisteinemia / Hipertensión Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Oxid Med Cell Longev Asunto de la revista: METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hiperhomocisteinemia / Hipertensión Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Oxid Med Cell Longev Asunto de la revista: METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: China